NasdaqGM - Delayed Quote USD

Loncar China BioPharma ETF (CHNA)

13.53 -0.01 (-0.07%)
At close: October 17 at 3:51 PM EDT

Top 10 Holdings (25.68% of Total Assets)

SymbolCompany% Assets
LEGN
Legend Biotech Corporation 3.07%
02359
02359 3.05%
6660.HK
AIM Vaccine Co., Ltd. 2.69%
1099.HK
Sinopharm Group Co. Ltd. 2.64%
6826.HK
Shanghai Haohai Biological Technology Co., Ltd. 2.62%
1952.HK
Everest Medicines Limited 2.58%
02196
02196 2.36%
BGNE
BeiGene, Ltd. 2.27%
00874
00874 2.22%
2005.HK
SSY Group Limited 2.17%

Sector Weightings

SectorCHNA
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Overall Portfolio Composition (%)

Stocks 99.11%
Bonds 0.00%

Equity Holdings

Price/Earnings 0.08
Price/Book 0.61
Price/Sales 0.87
Price/Cashflow 0.13
Median Market Cap --
3 Year Earnings Growth --

Bond Ratings

US Government 0.00%
AAA --
AA --
A --
BBB --
BB --
B --
Below B --
Other --

ETF Summary

The Advisor attempts to invest all, or substantially all, of its assets in the component securities and depositary receipts that make up the index. The index seeks to track the performance of a modified equal-weighted portfolio of companies directly involved in the growth of China's pharmaceutical and biotech related industries.

ETF Overview

Category China Region
Fund Family Loncar Investments
Net Assets --
YTD Daily Total Return 0.29%
Yield 0.00%
Legal Type Exchange Traded Fund

Related Tickers